It was shown earlier that, in Japanese quail the mechanism controlling the induction by testosterone of aromatase activity develops between embryonic days 10 and 14. The cellular processes underlying this activation have, however, not been investigated in detail. Here, we demonstrate that the increase in aromatase activity observed in neonates treated with testosterone propionate between postnatal days 1 and 3 results from the recruitment of additional populations of aromatase-immunoreactive cells that were not expressing the enzyme at detectable levels before. This recruitment concerns all brain nuclei normally expressing the enzyme even if it is more prominent in the ventromedial hypothalamus than in other nuclei.
Introduction
In many avian and mammalian species, the aromatization of testosterone into estradiol within the preoptic area, hypothalamus, plays a limiting role in the control of all aspects of male sexual behavior [1, 2] . In castrated male Japanese quail (Coturnix japonica) in particular, both consummatory (copulation sensu stricto) and appetitive (approaches of the female and rhythmic contractions of the cloacal gland in anticipation of copulation) aspects of male sexual behavior are activated by a treatment with exogenous testosterone but blocked by the concurrent administration of aromatase inhibitors [2, 3] . Similar results have been reported in rats and many other species (e.g. [4] ; for review see Refs. [2, 5] ). These and other observations have led, more than 30 years ago, to the formulation of the so-called 'aromatization hypothesis' according to which, many aspects of male sexual behavior in a large number of vertebrates are actually activated at the cellular level by the action of estrogens derived from the local aromatization of androgens [6] .
Interestingly, brain aromatase activity (AA) is itself controlled by testosterone. The enzymatic activity is basal in castrated individuals but increases 2-5-fold after treatment for a few days with exogenous testosterone. This phenomenon was originally discovered in an avian species, the ring dove (Streptopelia risoria) [7] , but was subsequently confirmed in a large number of species including mammals and birds [8] .
In quail, kinetic studies indicate that the testosteroneinduced increase in AA results from an increased maximal velocity (V max ) of the enzyme with no detectable change in its affinity (Kd) for the androgenic substrate suggesting that the increased AA mostly reflects an increased concentration of the enzyme rather than a modulation of its properties [9] . Immunohistochemical methods allowing an accurate visualization of aromatase in the avian brain confirmed this interpretation. Treatment of castrated birds with testosterone increases the number of preoptic and hypothalamic neurons that are immunoreactive for aromatase [10] indicating that under the influence of this androgen, more cells acquire a phenotype expressing the estrogen synthesizing enzyme. In-situ hybridization and polymerase chain reaction experiments further indicated that testosterone increases the concentration of aromatase mRNA and the numbers of cells that express this message in the preoptic area thus suggesting that testosterone is likely to activate the transcription of the corresponding gene and this represents the main route through which testosterone increases brain AA (for review see Ref. [2] ). Note, however, that preoptic AA can also be modulated within minutes by calcium-dependent phosphorylation processes that are themselves under the control of neurotransmitter activity (mainly glutamatergic inputs) [2, 3, 11] . Hence, a change in enzymatic activity does not necessarily reflect a modification of enzyme concentrations.
Detailed investigations indicated that testosterone does not affect aromatase equally in all hypothalamic and limbic nuclei. Assays of AA in nuclei microdissected by the Palkovits punch technique revealed a great anatomical variability in the magnitude of AA induction by testosterone [12] . Immunohistochemical studies similarly showed that the number of aromatase-immunoreactive (ARO-ir) cells increased more in the medial preoptic nucleus than in a population dorsal to the anterior commissure corresponding to the rostral part of the bed nucleus of the stria terminalis, pars medialis (named for short nucleus of the stria terminalis in the following; originally described as belonging to the septal region; [13, 14] ). Even within a single nucleus such as the medial preoptic nucleus, detailed analyses revealed a differential effect of testosterone on the numbers of ARO-ir cells in different parts of this structure [10] .
A few studies investigated the ontogeny of the induction by testosterone of brain AA in quail. AA is already detectable on day 10 of incubation (out of a 16-17-day incubation) but cannot apparently be increased by a treatment with testosterone at that early age [15] . The effects of testosterone on the enzyme can be observed starting at 14 days of incubation [15] and is clearly present after hatching. The increased activity is not associated with changes in the apparent Kd of the enzyme suggesting that like in adults, it results from an increased expression of the enzymatic protein [16] . The underlying mechanisms and anatomical specificity of this increase have, however, not been investigated. The present studies had a dual objective. We first sought to determine whether the testosterone-induced increase in AA observed in neonate quail results, like in adulthood, from an increased expression of the enzymatic protein associated or not with the recruitment of new ARO-ir positive cells. In a second step, we also tested whether the induction of AA by testosterone in neonates is anatomically differentiated like in adulthood or alternatively results from an equal recruitment of new ARO-ir in all nuclei.
Materials and methods

Animals and endocrine treatments
Experiments were performed on Japanese quail (C. japonica) chicks derived from eggs produced in our breeding colony at the University of Liège. Eggs were incubated in a forced-air incubator (39.51C, humidity 60%) and turned twice daily except during the last 2 days before hatching. The day of hatching was considered as postnatal day 1 (PN1). Chicks were raised in heterosexual groups at 381C under a long photoperiod (16 h light-8 h dark), with water and food available ad libitum. All experimental procedures were approved by the Ethics Committee for the Use of Animals at the University of Liège and were in agreement with the NIH Guide for the Care and Use of Laboratory Animals and the relevant Belgian laws on the protection of animals.
Male and female chicks were injected in the pectoral muscles on PN1 and PN2 with 1 mg of testosterone propionate per bird each time (Fluka 86541, Buchs, Switzerland) dissolved in 50 ml of sesame oil (Sigma S3547, St Louis, Missouri, USA) or with 50 ml of the vehicle. Animals were killed on PN3 by decapitation and sexed by gonadal inspection. Their brains were quickly removed from the skull and distributed in two groups.
For AA measurement, a first group of 20 birds were killed (10 testosterone propionate: seven male, three female; 10 oil: seven male, three female) and their brain was dissected to isolate the aromatase-rich hypothalamic and limbic areas. A coronal cut just rostral to the preoptic area and another coronal cut just caudal to the optic nerves removed the rostral and caudal parts of the brain. The optic lobes and cerebellum were additionally removed. The remaining samples (weight 203.9 ± 24.4 mg, mean ± standard deviation) were immediately frozen on dry-ice and stored at -751C until assay.
A second group of 20 brains (10 testosterone propionate: five male, five female; 10 oil: five male, five female) were collected for aromatase immunohistochemistry and fixed in acrolein as described earlier [2.5 h in acrolein 5% in phosphate buffer saline (PBS), two 30 min washes in PBS, cryoprotection on 30% sucrose in PBS and freezing on dry ice; [17] ].
Aromatase assay AA was measured in all samples by a method described earlier [18] and validated for the quail brain [19, 20] . Briefly, brain samples were homogenized within 1 ml of ice-cold TKE buffer (10 mM Tris-HCl pH 7.2, 150 mM KCl and 1 mM Na-EDTA). AA was quantified in triplicate aliquots of these homogenates by measuring the tritiated water production from [1b-3H]-androstenedione during 15 min incubations at 371C. Enzyme activity was expressed in fmol/mg fresh weight/h after correction of counts for quenching, recovery, blank values (aliquots of each sample incubated in the presence of an excess of the aromatase inhibitor, Vorozole, Janssen Pharmaceutica, Beerse, Belgium) and percentage of tritium in b-position in the substrate (for details see Refs. [19, 20] ).
Aromatase immunohistochemistry
Brains were cut on a cryostat in three series of 30 mm coronal sections and one series of free-floating sections were stained for aromatase by successive incubation in a rabbit antiquail aromatase antibody (1/3000, [21] for antibody preparation and validation) and a biotinylated goat anti-rabbit antibody (1/400, Dako E0432, Glostrup, Denmark). Staining was finally revealed with the avidin/ biotin system and the peroxidase substrate Vector SG kit (Vector Laboratories PK6100, SK4700, Burlingame, California, USA). Sections were mounted on slides, dried and covered with Eukitt Mounting Medium (Electron Microscopy Sciences 15320, Hatfield, Pennsylvania, USA). nucleus, the rostral part of the nucleus of the stria terminalis located dorsally to the anterior commissure and in the ventromedial hypothalamus located between the hypothalamic periventricular organ and the supraoptic decussation. Immunopositive cells were counted whether they displayed a negative nucleus surrounded by a clearly positive cytoplasm. Counts were performed with a camera lucida connected to the microscope in a rectangular field corresponding to 500 Â 750 mm. This rectangle was placed vertically over the medial preoptic nucleus but horizontally above the nucleus of the stria terminalis and ventromedial hypothalamus to cover the entire group of ARO-ir cells corresponding to these nuclei.
Statistics
Comparisons between groups were performed by two-way analyses of variance (ANOVA) with the sex of quail and endocrine conditions (testosterone propionate vs. oil) as factors. Immunohistochemical data were originally analyzed with a three-way ANOVA including the three nuclei as repeated factor. Means ± standard error of mean, significant for P value less than 0.05.
Results
Induction of brain aromatase activity by testosterone in the neonatal brain
This first experiment confirmed the previously described [15] effect of exogenous testosterone on AA in neonate quail chicks. The two-way ANOVA (sex and endocrine condition as factors) revealed an overall significant effect of the testosterone treatment of chicks on their AA [F(1,16) = 13.979, P = 0.0018; Fig. 1 ]. There was no overall sex difference in enzymatic activity [F(1,16) = 0.003, P = 0.9574] and no significant interaction between the two factors [F(1,16) = 2.959, P = 0.1047] suggesting that testosterone effects are identical in both sexes even if the increase in enzymatic activity was numerically larger in males than in females.
Effects of testosterone on the number of aromatase-immunoreactive cells in the neonatal brain
As described earlier in adult quail, ARO-ir cells of neonates were essentially observed in three clusters corresponding to the medial preoptic nucleus and nucleus of the stria terminalis, illustrated here at the level of the anterior commissure ( Fig. 2a ) and the ventromedial hypothalamus, shown at the level of the paraventricular organ (Fig. 2b) .
Treatment with testosterone propionate did not affect this overall neuroanatomical distribution and no additional brain area was shown to express the enzyme after androgen injections. Testosterone produced, however, a prominent increase in the number of cells expressing immunoreactive aromatase in the three brain areas. This was already obvious at low magnification ( Fig. 2a and b ) but is even clearer in photographs obtained at higher magnification in the medial preoptic nucleus ( Fig. 2c and  d) , nucleus of the stria terminalis ( Fig. 2e and f) and ventromedial hypothalamus ( Fig. 2g and h) .
Standardized counts of immunopositive cells in these three areas confirmed this experimental effect (Fig. 3) . A three-way ANOVA analyzing these cell numbers in the two sexes, two experimental treatments and three nuclei (repeated factor) identified an overall effect of the treatment with testosterone [F(1,16) = 24.210, P = 0.0002] but no major sex difference [F(1,16) = 3.960, P = 0.0640] and no interaction between these two factors [F(1,16) = 1.306, P = 0.2699]. The number of ARO-ir cells differed significantly between the three areas [F(2,32) = 34.192, P < 0.0001] but this anatomical difference was similar in both treatments and sexes and no second order interaction was observed (all P > 0.2058).
Separate analysis of the number of ARO-ir cells in each nucleus fully confirmed these overall conclusions. There was a significant effect of testosterone on the number of these cells in the medial preoptic nucleus [F(1,16) = 4.979, P = 0.0403], nucleus of the stria terminalis [F(1,16) = 22.525 P = 0.0002] and ventromedial hypothalamus [F(1,16) = 36.965, P < 0.0001], and these effects were never associated with sex differences nor with interactions between sex and endocrine condition (P > 0.05 in all cases).
Discussion
The present studies confirm the prominent induction of AA in the brain of neonate quail after treatment with androgens and show that this enzymatic change reflects, like in adult birds, an increase in the number of ARO-ir cells in three brain nuclei: the medial preoptic nucleus, nucleus of the stria terminalis and ventromedial hypothalamus. The increased enzymatic activity thus corresponds to the recruitment of neurons that were expressing small nondetectable amounts of aromatase and markedly increase this synthesis under the influence of androgens.
One could alternatively imagine that the increase in the number of ARO-ir cells corresponds to an increased stability of the enzymatic protein leading to a concentration build-up in neurons or to a change in conformation of the enzyme making it more available for recognition by the antibody. However, it is known that in adult quail, the effects of testosterone on AA are also paralleled by an increase in concentration of the corresponding mRNA suggesting a direct effect of the steroid (or its aromatized metabolites) on the transcription of the aromatase gene [2] . For parsimony reasons, we are therefore inclined to believe that the same mechanism is already developed in neonate quail.
For similar reasons, we also assume that the increased number of ARO-ir cells reflect a phenotypic change in neurons that were already present in the area but were not expressing detectable amount of the enzyme. Preoptic and hypothalamic cells are indeed postmitotic early during embryonic life (before day 14 of incubation, presumably earlier for neurons than glial cells; [22] ) and it is thus quite unlikely that new aromatase-positive neurons could be born and differentiate between PN1 and PN3 in these nuclei expressing aromatase.
It should also be noted that even if testosterone significantly increased AA and the number of ARO-ir cells in quail chicks, the magnitude of this increase was still lower than in adult birds (50-150% in chicks vs. 4-5-fold increase in adults [9, 13] ). The enzyme expression only reaches adult levels after sexual maturation takes place [23] and plasma testosterone rises at around weeks 6-7 post hatch [24] .
Although the effects of testosterone reached statistical significance in the three brain nuclei that were investigated, the average magnitude of the effects was markedly larger in the ventromedial hypothalamus than in the two other nuclei [increase of 47.5% in medial preoptic nucleus (more in males), 52.3% in nucleus of the stria terminalis and 150.9% in ventromedial hypothalamus]. This neuroanatomical difference in responsiveness is reminiscent of a similar difference response to testosterone that was reported in adult quail (medial preoptic nucleus > nucleus of the stria terminalis; [13, 14] ) but the relative magnitude of these changes is different in neonates and adults. The origins of this anatomical specificity in the controls of aromatase are unknown at present and presumably relate to the interaction with the local neurochemical environment and/or use of alternative promoters for the control of the aromatase gene transcription. The function, if any, of this age-related change in the magnitude of testosterone effects in individual brain nuclei could only be specified by the experimental analysis of the specific physiological significance of AA in the three nuclei at the two ages that were considered.
Conclusion
Altogether, these data strongly suggest that the testosterone-sensitive mechanisms controlling aromatase expression in the quail brain are already mature at hatching. The testosterone-induced increase in brain AA in neonates reflects, like in adults, the recruitment of additional neurons that express significant amounts of the enzyme even if this enzymatic expression will only reach its maximal levels in adulthood.
